BJERKHOLT ERIC (CHIEF FINANCIAL OFFICER) sold 19.3% of their position (9.58K shares) of MIRUM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $728.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/12/2025ACC: 0001415889-25-024462
Officer· CHIEF FINANCIAL OFFICER
Since Jan 2026
-9.58K
Net shares
Net seller
$728.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
18.33K acquired · 27.91K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.33K
Price / share
—
Trade value
—
% of position
58.8%
9/11/2025
31.19K→49.52K
Common Stock
Direct
Shares
−9.58K
Price / share
$76.01
Trade value
$728.02K
% of position
19.3%
9/12/2025
49.52K→39.95K
Total
Net shares
+8.76K
Net value
-$728.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2025 | M · Option Exercise | +18.33K | — | — | 58.8% | 31.19K | 49.52K |
| Common Stock Direct | 9/12/2025 | S · Sale | −9.58K | $76.01 | $728.02K | 19.3% | 49.52K | 39.95K |
| Total | +8.76K | -$728.02K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
18.33K shares
Shares
−18.33K
Strike price
Held after
18.33K
Exercisable
—
9/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock18.33K shares | 9/11/2025 | M · Option Exercise | −18.33K | — | 18.33K |